Homology Medicines - Stock Split History | FIXX

Stock split history for Homology Medicines since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Homology Medicines Annual Stock Splits
Homology Medicines Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.704B $0.002B
Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $12.451B 4.62
Dr Reddy's Laboratories (RDY) India $8.661B 20.74
Mylan (MYL) United States $8.369B 3.60
Bausch Health Cos (BHC) Canada $6.227B 4.12
ASPEN PHARMACR (APNHY) South Africa $3.925B 0.00
BridgeBio Pharma (BBIO) United States $3.847B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.228B 10.77
Amphastar Pharmaceuticals (AMPH) United States $0.993B 51.19
Assembly Biosciences (ASMB) United States $0.792B 0.00
Voyager Therapeutics (VYGR) United States $0.508B 0.00
Personalis (PSNL) United States $0.470B 0.00
CymaBay Therapeutics (CBAY) United States $0.239B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.204B 0.28
Sol-Gel Technologies (SLGL) Israel $0.171B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.085B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.072B 0.00
China Pharma Holdings (CPHI) China $0.025B 0.00
Teligent (TLGT) United States $0.012B 0.00